Complications during the pregnancy about disorders for the fetal fatty acid mitochondrial b-oxidation

Rilely CA. Acute fatty liver of pregnancy. Semin. Liver. Dis. 1987; 7: 47-54.

Fallon HJ, Riely CA. Liver diseases. In: Burrow GN, Ferris TF (eds) Medical complications during pregnancy.W.B. Saunders Co., Philadelphia, 1995; pp. 307-342.

Riely CA. Liver diseases in pregnancy. In: Kaplowitz. (ed) Liver and biliary diseases. William & Wilkins, Baltimore. 1992; pp. 432-441.

Kaplan MM. Acute fatty liver of pregnancy. N. Engl. J. Med. 1985; 313: 367-370.

Davies MH, Wilkinson SP, Hanid MA, et al. Acute liver disease with encephalopathy and renal failure in late pregnancy and early puerperium-a study of fourteen patients. Br. J. Obstet. Gynecol. 1980; 87: 1005-1014.

Ockner SA, Brunt EM, Cohn SM, et al. Fulminant hepatic failure caused by acute fatty liver of pregnancy treated by orthotopic transplantation.Hepatology.1990; 11: 59-64.

Sibai BM, Ramadan MK, Usta I, et al. Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liverenzymes, and low platelets. Am J Obstet. Gynecol. 1993; 169: 1000-1006.

Alberty R, Albertyová D. Biological variation of free and total carnitine in serum of healthy subjects. Clin. Chem. 1997; 43: 12: 2441-2443.

Bennet MJ, Rinaldo P, Strauss AW. Inborn errors of mitochondrial fatty acid oxidation. Clin. Rev. Clin. Lab. Sci. 2000; 37: 1: 1-44.

Goodridge AG. Regulation of fatty acids synthesis in isolated hepatocytes prepared from the livers of neonatal chicks. J. Biol. Chem. 1971; 248: 1924-1931.

Schultz H. Oxidation of fatty acids in: Biochemistry of lipids, lipoproteins and membranes. Elsevier Science. Vance D.E. ed. 996. pp. 75.

Nordlie RC, Foster JD. Regulation of glucose production by the liver. Annu. Rev. Nutr. 1999; 19: 379-406.

Daum G, Vance JE. Import of lipids into mitochondria. Prog. Lipid Res. 1997; 36:103-130.

Hashimoto T. Peroxisomal b-oxidation: Enzymology and molecular biology. Annals N.Y. Acad. Sci. 1997; 811: 86-98.

Hashimoto T. Peroxisomal b-oxidation enzymes. Neurochemical Research.1999; 24(4): 551-563.

Lazarow PB, Moser HW. Disorders of peroxisome biogenesis. In : Scriver CR., Beaudet AL, Sly W, Valle D. (eds). The metabolic and molecular bases of inherited metabolic diseases. 7th ed. New York : McGraw-Hill. 1995; Pp. 2287-2324.

Hamilton JA. Fatty acid transport: difficult or easy? J. Lipid Res.1998; 39: 467-481.

Brivet M, Boutron A, Slama A, et al. Defects in activation and transport of fatty acids. J. Inher. Metab. Dis. 1999; 22: 428-44.

Eaton S, Bartlett K, and Pourfarzam M. Mammalian mitochondria b-oxidation. Biochem. J. 1996; 320: 345-357.

Sue CM, Hirano M, DiMauro S, et al. Neonatal presentations of mitochondrial metabolic disorders. Seminars in Perinatology. 1999; 23(2): 113-124.

Rasmussen BB, Wolfe RR. Regulation of fatty acid oxidation in skeletal muscle. Annu. Rev. Nut. 1999;19: 463-484.

Verhoeven NM, Jakobs C, Ten Brink HJ, et al. Studies on the oxidation of phytanic acid and pristanic acid in human fibroblasts by acylcarnitine analyisis. J. Inher. Metab. Dis. 1998; 21: 753-760.

Ribes A, Briones P, Rodés M. Advances in biochemistry in the understanding of neurometabolic disorders. Rev. Neurol. 1999; 28: 161: 11-15.

Bonnefont JP, Demaugre F, Prip-Buus C, et al. Carnitine palmitoyltransferase deficiencies. Mol. Gen. Metabolism. 1999; 68: 424-440.

Isada NB, Martin LS, Evans MI. Prenatal diagnosis in the molecular age. In: Neonatology. Avery, Fletcher ME, McDonald MG (eds). 5th ed. Lippincott Williams and Wilkins. London. 1999; pp. 111-123.

Roe Ch, and Coates M. Mitochondrial fatty acid oxidation disorders. In: The metabolic and molecular bases of inherited disease. CD-ROM. de. Scriver CR, Beaudet AL, Sly WS, Valle D. (editors).McGraw-Hill. New York. 1997; Ch 45.

Lteif AN, Schwenk WF. Hypoglycemia in infants and children. Endocrinology and metabolism clinics of North America. 1999; 28(3): 619-648.

Moser HW, Moser AB. Measurement of saturated very long chain fatty acids in plasma. In: Techniques in diagnostic Human Biochemical Genetics: a laboratory manual. Wiley-Liss Inc. 1991; pp. 177-192.

Greter J, Jacobson CE. Urinary organic acids: isolation and quantification for routine metabolic screening. Clin. Chem. 1987; 33(4): 473-480.

Stevens RD, Hillman SL, Worthy S, et al. Assay for free and total carnitine in human plasma using tandem mass spectrometry. Clin. Chem. 2000; 46: 727-729.

Osorio JH, Pourfarzam M. Plasma free and total carnitine in children measured by tandem mass spectrometry. 2001. In preparation.

Millington DS, Chace DH, Hillman SL, et al. Diagnosis of Metabolic Disease. Diagnosis of metabolic disease. In: Matsudo T, Capriolo RM, Gross ML, Sevama Y. (eds). Biological Mass Spectrometry: Present and future. 1994; pp. 559-579.

Pourfarzam M, Schaefer J, Turnbull DM, et al. Analysis of Fatty Acid Oxidation Intermediates in Cultured Fibroblasts to Detect Mitochondrial Oxidation Disorders. Clin. Chem. 1994; 40/12: 2267-2275.

Schaefer J, Pourfarzam M, Bartlett K, et al. Fatty acid oxidation in peripheral blood cells: characterization and use for the diagnosis of fatty acid oxidation. Pediatr. Res.1995; 37: 345-360.

Ziadeh R, Hoffman EP, Finegold DN. Medium Chain Acyl-CoA Dehydrogenase Deficiency in Pennsylvania: Neonatal Screening Shows High Incidence and Unexpected Mutation Frequencies. Pediatric Research.1995; 37/5: 675-678.

Schoeman MN, Batey RG, Wilcken B. Recurrent acute fatty liver of pregnancy associated with a fatty-acid oxidation defect in the offspring. Gastroenterology.1991; 100: 544-548.

Wilcken B, Leung KC, Hammond J, et al. Pregnancy and fetal long-chain 3-hydroxyacyl coenzyme A dehydrogenase deficiency. Lancet. 1993; 341: 408-410.

Reyes H, Sandoval L, Wainstein A, et al. Acute fatty liver of pregnancy: a clinical study of 12 episodes in 11 patients. Gut. 1994; 35: 101-106.

Treem WR, Rinaldo P, Hale DE, et al. Acute fatty liver of the pregnancy and long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. Hepatology. 1994; 19: 339-345.

Sims HF, Brackett JC, Powell CK, et al. The molecular basis of pediatric long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency associated with maternal acute fatty liver of pregnancy. Proc. Natl. Acad. Sci. USA.1995; 92: 841-845.

Treem WR, Shoup ME, Hale DF, et al. Acute fatty liver of pregnancy, hemolysis, elevated liver enzymes, and low platelets syndrome, and long chain 3-hydroxyacyl-Coenzyme A dehydrogenase deficiency. Am. J. Gastroenterology. 1996; 91(11): 2292-2300.

Isaacs JD, Sims HF, Poell CK, et al. Maternal acute fatty liver of pregnancy associated with fetal trifunctional protein deficiency:molecular characterization of a novel maternal mutant allele. Pediatric Research. 1996; 40(3): 393-398.

Ibdah JA, Dasouki MJ, Strauss AW. Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: variable expressivity of maternal illness during pregnancy and unusual presentation with infantile cholestasis and hypocalcemia.

Innes AM, Seargeant K, Balachandra CR, et al. Hepatic carnitine palmitoytransferase I deficiency presenting as maternal illness in pregnancy. Pediatr. Res. 2000; 47: 43-45.

Rinaldo P, Studinski L, Matern A. Prenatal diagnosis of disorders of fatty acid transport and mitochondrial oxidation. Prenat. Diagn. 2001; 21: 52-54.

Osorio JH. Metabolismo de los lípidos durante el embarazo. Rev. Col. Obstet. Ginec. 2000; 51(2): 113-117.

Wickens D, Wilkins MH, Lunec J, et al. Free-radical oxidation (peroxidation)products in plasma in normal and abnormal pregnancy. Ann. Clin. Biochem. 1981; 18: 158-162.

Eisele JW, Barker EA, Smuckeler EA. Lipid content in the liver of fatty metamorphosis of pregnancy. Am J Pathol. 1975; 81: 545-560.

Tein I. Metabolic disease in the fetus predisposes to maternal hepatic complications of pregnancy. Pediatr. Res. 2000; 47: 1.

Dreifuss FE, Larger DH, Moline KA, et al. Valproic acid hepatic fatalities. II.US experience since 1984. Neurology. 1989; 39: 201-207.

Tein I. Metabolic myopathies. In: Bodensteiner JB, Goebel HH (eds). Seminars in pediatric neurology volume 3. W.B. Saunders Co, Philadelphia.1996; 59-98.

Barton JR, Riely CA, Adamec TA, et al. Hepatic histopathologic condition does not correlate with laboratory abnormalities in HELLP syndrome (hemolysis, elevated enzymes, and low platelet count). Am J Obstet Gynecol. 1992; 167: 1538-1543.

Tyni T. Pregnancy complications are frequent in long-chain-3-hydroxyacyl CoA deficiency. Am J Obstet Gynecol. 1998;178: 603-608.

Hale DE, Bennet MJ. Fatty acid oxidation disorders: a new class of metabolic diseases. J Pediatr.1992; 121: 1-11.